OpSens Awarded Interventional Specialty Diagnostics Agreement with Premier for OptoWire III

QUEBEC CITY , July 11, 2022 /CNW/ - OpSens Inc. . ("OpSens" or the "Company") (TSX:OPS ) (OTCQX:OPSSF ), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology has been awarded a national group purchasing agreement for Interventional Specialty Diagnostics with Premier, Inc. (Premier), a leading healthcare improvement company uniting an alliance with approximately 4,400 U.S. hospitals and health systems. Effective July 1 st , the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for OptoWire III and related system components. Louis Laflamme , ... Full story available on Benzinga.com